Xsensio Secures $7M in Oversubscribed Series A Funding for Advanced Biosensing Xsensio SA has successfully closed a $7 million Series A funding round to enhance its wearable biosensing technology, Lab-on-Skin©. This will accelerate its clinical deployment.

Xsensio Secures $7M in Oversubscribed Series A Funding for Advanced Biosensing #Switzerland #Lausanne #Xsensio #Lab-on-Skin #Clinical_Biosensing